FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (VistaPharm, LLC)

View source ↗

Summary

FDA approves a supplemental application for mycophenolate mofetil (VistaPharm, LLC), endorsing a generic product for prevention of organ transplant rejection in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Transplant Rejection
• Hepatic Transplant Rejection
• Renal Transplant Rejection

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

SUPPL AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)